Article

ATryn®: 1st GE (genetically engineered) animal success story for production of a human recombinant pharmaceutical

2014-01-01

Abstract excerpt

No abstract is available from the source.

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 54c1b133-ea6f-5d86-bf2f-45841071e221
DOI: 10.1186/1753-6561-8-s4-o4
PMCID: PMC4204361

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

ATryn®: 1st GE (genetically engineered) animal success story for production of a human recombinant pharmaceuticalDOI 10.1186/1753-6561-8-s4-o4Read

Foundation Review: Transgenic animals and their impact on the drug discovery industrySemantic proximity Read

EMA commentary on the guideline on quality, nonclinical and clinical aspects of medicinal products containing genetically modified cellsSemantic proximity Read

[Genetically-engineered model animals].Semantic proximity Read

BJCP-EMA commentaries on the guideline on quality, non-clinical and clinical aspects of medicinal products containing genetically modified cells.Semantic proximity Read

Unravelling the essential elements for recombinant adeno-associated virus (rAAV) production in animal cell-based platformsSemantic proximity Read

The Past, Present, and (Near) Future of Gene Therapy and Gene EditingSemantic proximity Read

The expanding menagerie: animal models of hemophilia A.Semantic proximity Read

Review of cardiac safety in onasemnogene abeparvovec gene replacement therapy: translation from preclinical to clinical findingsSemantic proximity Read

Timing of Gene Therapy Interventions: The Earlier, the BetterSemantic proximity Read

Considerations for manufacturing of cell and gene medicines for clinical developmentSemantic proximity Read

Translational Safety Genetics.Semantic proximity Read

Gene therapy enters the pharma market: the short story of a long journey.Semantic proximity Read